OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Fibroblast activation protein-based theranostics in cancer research: A state-of-the-art review
Liang Zhao, Jianhao Chen, Yizhen Pang, et al.
Theranostics (2022) Vol. 12, Iss. 4, pp. 1557-1569
Open Access | Times Cited: 112
Liang Zhao, Jianhao Chen, Yizhen Pang, et al.
Theranostics (2022) Vol. 12, Iss. 4, pp. 1557-1569
Open Access | Times Cited: 112
Showing 1-25 of 112 citing articles:
Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
Hao Zhang, Xinghai Yue, Zhe Chen, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 123
Hao Zhang, Xinghai Yue, Zhe Chen, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 123
Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies
Bastiaan M. Privé, Mohamed A. Boussihmad, Bart Timmermans, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 7, pp. 1906-1918
Open Access | Times Cited: 63
Bastiaan M. Privé, Mohamed A. Boussihmad, Bart Timmermans, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 7, pp. 1906-1918
Open Access | Times Cited: 63
FAPI-avid nonmalignant PET/CT findings: An expedited systematic review
Morten Bentestuen, Noor Al-Obaydi, Helle D. Zacho
Seminars in Nuclear Medicine (2023) Vol. 53, Iss. 5, pp. 694-705
Open Access | Times Cited: 40
Morten Bentestuen, Noor Al-Obaydi, Helle D. Zacho
Seminars in Nuclear Medicine (2023) Vol. 53, Iss. 5, pp. 694-705
Open Access | Times Cited: 40
Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy
Tianchen Guo, Junfen Xu
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 3, pp. 1095-1116
Open Access | Times Cited: 17
Tianchen Guo, Junfen Xu
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 3, pp. 1095-1116
Open Access | Times Cited: 17
PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using68Ga-FAP-2286: Comparison with18F-FDG and68Ga-FAPI-46 in a Single-Center, Prospective Study
Yizhen Pang, Liang Zhao, Tinghua Meng, et al.
Journal of Nuclear Medicine (2022) Vol. 64, Iss. 3, pp. 386-394
Open Access | Times Cited: 53
Yizhen Pang, Liang Zhao, Tinghua Meng, et al.
Journal of Nuclear Medicine (2022) Vol. 64, Iss. 3, pp. 386-394
Open Access | Times Cited: 53
Development of FAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI Radioligand Therapy
Yizhen Pang, Liang Zhao, Jianyang Fang, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. 9, pp. 1449-1455
Open Access | Times Cited: 34
Yizhen Pang, Liang Zhao, Jianyang Fang, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. 9, pp. 1449-1455
Open Access | Times Cited: 34
Clinical Evaluation of68Ga-FAPI-RGD for Imaging of Fibroblast Activation Protein and Integrin αvβ3in Various Cancer Types
Liang Zhao, Xuejun Wen, Weizhi Xu, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. 8, pp. 1210-1217
Open Access | Times Cited: 30
Liang Zhao, Xuejun Wen, Weizhi Xu, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. 8, pp. 1210-1217
Open Access | Times Cited: 30
[68Ga]Ga-FAPI-04 PET MRI/CT in the evaluation of gastric carcinomas compared with [18F]-FDG PET MRI/CT: a meta-analysis
Yawen Wang, Wenhao Luo, Ye Li
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 26
Yawen Wang, Wenhao Luo, Ye Li
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 26
Clinical Advances and Perspectives in Targeted Radionuclide Therapy
Nicolas Lepareur, Barthélémy Ramée, Marie Mougin‐Degraef, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1733-1733
Open Access | Times Cited: 20
Nicolas Lepareur, Barthélémy Ramée, Marie Mougin‐Degraef, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1733-1733
Open Access | Times Cited: 20
Peptide receptor radionuclide therapy combinations for neuroendocrine tumours in ongoing clinical trials: status 2023
Gianpaolo di Santo, Giulia Santo, Anna Sviridenko, et al.
Theranostics (2024) Vol. 14, Iss. 3, pp. 940-953
Open Access | Times Cited: 9
Gianpaolo di Santo, Giulia Santo, Anna Sviridenko, et al.
Theranostics (2024) Vol. 14, Iss. 3, pp. 940-953
Open Access | Times Cited: 9
Design, Preclinical Evaluation, and Clinical Translation of68Ga-FAPI-LM3, a Heterobivalent Molecule for PET Imaging of Nasopharyngeal Carcinoma
Liang Zhao, Yizhen Pang, Jianyang Fang, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. 3, pp. 394-401
Open Access | Times Cited: 9
Liang Zhao, Yizhen Pang, Jianyang Fang, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. 3, pp. 394-401
Open Access | Times Cited: 9
Fibroblast Activation Protein Inhibitor Tracers and Their Preclinical, Translational, and Clinical Status in China
Liang Zhao, Fei Kang, Yizhen Pang, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. Supplement 1, pp. 4S-11S
Closed Access | Times Cited: 8
Liang Zhao, Fei Kang, Yizhen Pang, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. Supplement 1, pp. 4S-11S
Closed Access | Times Cited: 8
Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and Peptides
Richard P. Baum, Emil Novruzov, Tianzhi Zhao, et al.
Seminars in Nuclear Medicine (2024) Vol. 54, Iss. 4, pp. 537-556
Closed Access | Times Cited: 8
Richard P. Baum, Emil Novruzov, Tianzhi Zhao, et al.
Seminars in Nuclear Medicine (2024) Vol. 54, Iss. 4, pp. 537-556
Closed Access | Times Cited: 8
211At-Labeled Nanoscale Polydopamine Decorated with FAPI for Synergistic Targeted-Alpha Therapy and Photothermal Therapy of Glioma
Feize Li, Huan Ma, Hao Luo, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 7, pp. 6831-6838
Closed Access | Times Cited: 6
Feize Li, Huan Ma, Hao Luo, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 7, pp. 6831-6838
Closed Access | Times Cited: 6
FAP-Targeted SPECT/CT and PET/CT Imaging for Breast Cancer Patients
Jeremy McGale, Sakshi Khurana, Harrison Howell, et al.
Clinical Nuclear Medicine (2025)
Closed Access
Jeremy McGale, Sakshi Khurana, Harrison Howell, et al.
Clinical Nuclear Medicine (2025)
Closed Access
Impact of 68Ga-FAPI positron emission tomography/computed tomography on staging and tumor management in patients with gastric cancer
Shunyu Zhang, Minggang Su, Qianrui Li, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 1
Open Access
Shunyu Zhang, Minggang Su, Qianrui Li, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 1
Open Access
Fibroblast activation protein peptide-targeted NIR-I/II fluorescence imaging for stable and functional detection of hepatocellular carcinoma
En Lin, Miaomiao Song, Bo Wang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Closed Access
En Lin, Miaomiao Song, Bo Wang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Closed Access
Assessment of viable tumours by [68Ga]Ga-FAPI-04 PET/CT after local regional treatment in patients with hepatocellular carcinoma
Dongling Zhu, Shuang Song, Sijuan Zou, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Closed Access
Dongling Zhu, Shuang Song, Sijuan Zou, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Closed Access
Prognostic and diagnostic value of [18F]FDG, 11C-acetate, and [68Ga]Ga-FAPI-04 PET/CT for hepatocellular carcinoma
Hao Xu, Hao Wang, S W Yu, et al.
European Radiology (2025)
Closed Access
Hao Xu, Hao Wang, S W Yu, et al.
European Radiology (2025)
Closed Access
99mTc-FAPI-46 Scan and 177Lu-FAPI-2286 Treatment in a Patient With Nasopharyngeal Carcinoma
Somaye Barashki, Bentolhoda Hadad, Nasrin Raeisi, et al.
Clinical Nuclear Medicine (2025)
Closed Access
Somaye Barashki, Bentolhoda Hadad, Nasrin Raeisi, et al.
Clinical Nuclear Medicine (2025)
Closed Access
Toward Personalized Immunotherapeutic Drug Monitoring with Multiplexed Extended‐Gate Field‐Effect‐Transistor Biosensors
Trang‐Anh Nguyen‐Le, Christin Neuber, Isli Cela, et al.
Small Science (2025)
Open Access
Trang‐Anh Nguyen‐Le, Christin Neuber, Isli Cela, et al.
Small Science (2025)
Open Access
Evaluation of a Novel Gd-FAPI Dimer Molecular Probe Targeting Fibroblast Activation Protein for Imaging of Solid Tumors
Xiaohui Wang, Caiyu Zhuang, Xinhui Zheng, et al.
Molecular Pharmaceutics (2025)
Open Access
Xiaohui Wang, Caiyu Zhuang, Xinhui Zheng, et al.
Molecular Pharmaceutics (2025)
Open Access
A Dimeric FAP-Targeting Small-Molecule Radioconjugate with High and Prolonged Tumor Uptake
Andrea Galbiati, Aureliano Zana, Matilde Bocci, et al.
Journal of Nuclear Medicine (2022) Vol. 63, Iss. 12, pp. 1852-1858
Open Access | Times Cited: 32
Andrea Galbiati, Aureliano Zana, Matilde Bocci, et al.
Journal of Nuclear Medicine (2022) Vol. 63, Iss. 12, pp. 1852-1858
Open Access | Times Cited: 32
Development of Fibroblast Activation Protein Inhibitor-Based Dimeric Radiotracers with Improved Tumor Retention and Antitumor Efficacy
Liang Zhao, Jianhao Chen, Yizhen Pang, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 10, pp. 3640-3651
Closed Access | Times Cited: 27
Liang Zhao, Jianhao Chen, Yizhen Pang, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 10, pp. 3640-3651
Closed Access | Times Cited: 27
Synthesis and Evaluation of 99mTc-Labeled FAP Inhibitors with Different Linkers for Imaging of Fibroblast Activation Proteins in Tumors
Qing Ruan, Qianna Wang, Yuhao Jiang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 7, pp. 4952-4960
Closed Access | Times Cited: 19
Qing Ruan, Qianna Wang, Yuhao Jiang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 7, pp. 4952-4960
Closed Access | Times Cited: 19
